The global market for Lateral Flow Assay Services was valued at US$ 5273 million in the year 2024 and is projected to reach a revised size of US$ 8572 million by 2031, growing at a CAGR of 7.2% during the forecast period.
Lateral flow assay services refer to a set of professional offerings centered around the use of lateral flow assays, which are rapid, point-of-care diagnostic tools. In a lateral flow assay, a sample (such as blood, urine, saliva, or other bodily fluids) is applied to one end of a strip or membrane. As the sample migrates laterally across the strip due to capillary action, it interacts with specific reagents immobilized on the membrane. These reagents typically include antibodies or other recognition molecules that can bind to target analytes present in the sample, such as disease markers, drugs, or hormones. The assay is designed so that a visible line or signal appears at specific locations on the strip if the target analyte is present, indicating a positive result, while the absence of the line signifies a negative result. Lateral flow assay services may encompass various aspects, including the development and optimization of custom assays tailored to specific analytes or applications, manufacturing of the assay strips or kits, quality control and validation to ensure accuracy and reliability, and sometimes even providing on-site testing or interpretation of results. These services are widely utilized in diverse fields such as healthcare for disease diagnosis (e.g., detecting infectious diseases like COVID-19, pregnancy testing), food safety for detecting contaminants or allergens, environmental monitoring for pollutants, and veterinary medicine for diagnosing animal diseases.
North American market for Lateral Flow Assay Services is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Lateral Flow Assay Services is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global market for Lateral Flow Assay Services in Medical Diagnostics is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global companies of Lateral Flow Assay Services include Sigma-Aldrich, BBI Solutions, RayBiotech, DCN Dx, Fortis Life Sciences, Cytodiagnostics, Abingdon Health, Cytiva, Attogene, Poly-Dtech, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Lateral Flow Assay Services, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Lateral Flow Assay Services.
The Lateral Flow Assay Services market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Lateral Flow Assay Services market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Lateral Flow Assay Services companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
麻豆原创 Segmentation
By Company
Sigma-Aldrich
BBI Solutions
RayBiotech
DCN Dx
Fortis Life Sciences
Cytodiagnostics
Abingdon Health
Cytiva
Attogene
Poly-Dtech
Lumos Diagnostics
RAPIvD ltd
JOYSBIO
Leinco
Leadgene Biomedical
Biotem
Biocompare
nanoComposix
Creative Diagnostics
Lateral Dx
Segment by Type
Lateral Flow Assay Development Services
Lateral Flow Assay Manufacturing Services
Others
Segment by Application
Medical Diagnostics
Food Safety
Environmental Monitoring
Veterinary Medicine
Other
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Lateral Flow Assay Services company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Report Overview
1.1 Study Scope
1.2 麻豆原创 Analysis by Type
1.2.1 Global Lateral Flow Assay Services 麻豆原创 Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Lateral Flow Assay Development Services
1.2.3 Lateral Flow Assay Manufacturing Services
1.2.4 Others
1.3 麻豆原创 by Application
1.3.1 Global Lateral Flow Assay Services 麻豆原创 Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Medical Diagnostics
1.3.3 Food Safety
1.3.4 Environmental Monitoring
1.3.5 Veterinary Medicine
1.3.6 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Lateral Flow Assay Services 麻豆原创 Perspective (2020-2031)
2.2 Global Lateral Flow Assay Services Growth Trends by Region
2.2.1 Global Lateral Flow Assay Services 麻豆原创 Size by Region: 2020 VS 2024 VS 2031
2.2.2 Lateral Flow Assay Services Historic 麻豆原创 Size by Region (2020-2025)
2.2.3 Lateral Flow Assay Services Forecasted 麻豆原创 Size by Region (2026-2031)
2.3 Lateral Flow Assay Services 麻豆原创 Dynamics
2.3.1 Lateral Flow Assay Services Industry Trends
2.3.2 Lateral Flow Assay Services 麻豆原创 Drivers
2.3.3 Lateral Flow Assay Services 麻豆原创 Challenges
2.3.4 Lateral Flow Assay Services 麻豆原创 Restraints
3 Competition Landscape by Key Players
3.1 Global Top Lateral Flow Assay Services Players by Revenue
3.1.1 Global Top Lateral Flow Assay Services Players by Revenue (2020-2025)
3.1.2 Global Lateral Flow Assay Services Revenue 麻豆原创 Share by Players (2020-2025)
3.2 Global Top Lateral Flow Assay Services Players by Company Type and 麻豆原创 Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Lateral Flow Assay Services Revenue
3.4 Global Lateral Flow Assay Services 麻豆原创 Concentration Ratio
3.4.1 Global Lateral Flow Assay Services 麻豆原创 Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Lateral Flow Assay Services Revenue in 2024
3.5 Global Key Players of Lateral Flow Assay Services Head office and Area Served
3.6 Global Key Players of Lateral Flow Assay Services, Product and Application
3.7 Global Key Players of Lateral Flow Assay Services, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Lateral Flow Assay Services Breakdown Data by Type
4.1 Global Lateral Flow Assay Services Historic 麻豆原创 Size by Type (2020-2025)
4.2 Global Lateral Flow Assay Services Forecasted 麻豆原创 Size by Type (2026-2031)
5 Lateral Flow Assay Services Breakdown Data by Application
5.1 Global Lateral Flow Assay Services Historic 麻豆原创 Size by Application (2020-2025)
5.2 Global Lateral Flow Assay Services Forecasted 麻豆原创 Size by Application (2026-2031)
6 North America
6.1 North America Lateral Flow Assay Services 麻豆原创 Size (2020-2031)
6.2 North America Lateral Flow Assay Services 麻豆原创 Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Lateral Flow Assay Services 麻豆原创 Size by Country (2020-2025)
6.4 North America Lateral Flow Assay Services 麻豆原创 Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Lateral Flow Assay Services 麻豆原创 Size (2020-2031)
7.2 Europe Lateral Flow Assay Services 麻豆原创 Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Lateral Flow Assay Services 麻豆原创 Size by Country (2020-2025)
7.4 Europe Lateral Flow Assay Services 麻豆原创 Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Lateral Flow Assay Services 麻豆原创 Size (2020-2031)
8.2 Asia-Pacific Lateral Flow Assay Services 麻豆原创 Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Lateral Flow Assay Services 麻豆原创 Size by Region (2020-2025)
8.4 Asia-Pacific Lateral Flow Assay Services 麻豆原创 Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Lateral Flow Assay Services 麻豆原创 Size (2020-2031)
9.2 Latin America Lateral Flow Assay Services 麻豆原创 Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Lateral Flow Assay Services 麻豆原创 Size by Country (2020-2025)
9.4 Latin America Lateral Flow Assay Services 麻豆原创 Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Lateral Flow Assay Services 麻豆原创 Size (2020-2031)
10.2 Middle East & Africa Lateral Flow Assay Services 麻豆原创 Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Lateral Flow Assay Services 麻豆原创 Size by Country (2020-2025)
10.4 Middle East & Africa Lateral Flow Assay Services 麻豆原创 Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Sigma-Aldrich
11.1.1 Sigma-Aldrich Company Details
11.1.2 Sigma-Aldrich Business Overview
11.1.3 Sigma-Aldrich Lateral Flow Assay Services Introduction
11.1.4 Sigma-Aldrich Revenue in Lateral Flow Assay Services Business (2020-2025)
11.1.5 Sigma-Aldrich Recent Development
11.2 BBI Solutions
11.2.1 BBI Solutions Company Details
11.2.2 BBI Solutions Business Overview
11.2.3 BBI Solutions Lateral Flow Assay Services Introduction
11.2.4 BBI Solutions Revenue in Lateral Flow Assay Services Business (2020-2025)
11.2.5 BBI Solutions Recent Development
11.3 RayBiotech
11.3.1 RayBiotech Company Details
11.3.2 RayBiotech Business Overview
11.3.3 RayBiotech Lateral Flow Assay Services Introduction
11.3.4 RayBiotech Revenue in Lateral Flow Assay Services Business (2020-2025)
11.3.5 RayBiotech Recent Development
11.4 DCN Dx
11.4.1 DCN Dx Company Details
11.4.2 DCN Dx Business Overview
11.4.3 DCN Dx Lateral Flow Assay Services Introduction
11.4.4 DCN Dx Revenue in Lateral Flow Assay Services Business (2020-2025)
11.4.5 DCN Dx Recent Development
11.5 Fortis Life Sciences
11.5.1 Fortis Life Sciences Company Details
11.5.2 Fortis Life Sciences Business Overview
11.5.3 Fortis Life Sciences Lateral Flow Assay Services Introduction
11.5.4 Fortis Life Sciences Revenue in Lateral Flow Assay Services Business (2020-2025)
11.5.5 Fortis Life Sciences Recent Development
11.6 Cytodiagnostics
11.6.1 Cytodiagnostics Company Details
11.6.2 Cytodiagnostics Business Overview
11.6.3 Cytodiagnostics Lateral Flow Assay Services Introduction
11.6.4 Cytodiagnostics Revenue in Lateral Flow Assay Services Business (2020-2025)
11.6.5 Cytodiagnostics Recent Development
11.7 Abingdon Health
11.7.1 Abingdon Health Company Details
11.7.2 Abingdon Health Business Overview
11.7.3 Abingdon Health Lateral Flow Assay Services Introduction
11.7.4 Abingdon Health Revenue in Lateral Flow Assay Services Business (2020-2025)
11.7.5 Abingdon Health Recent Development
11.8 Cytiva
11.8.1 Cytiva Company Details
11.8.2 Cytiva Business Overview
11.8.3 Cytiva Lateral Flow Assay Services Introduction
11.8.4 Cytiva Revenue in Lateral Flow Assay Services Business (2020-2025)
11.8.5 Cytiva Recent Development
11.9 Attogene
11.9.1 Attogene Company Details
11.9.2 Attogene Business Overview
11.9.3 Attogene Lateral Flow Assay Services Introduction
11.9.4 Attogene Revenue in Lateral Flow Assay Services Business (2020-2025)
11.9.5 Attogene Recent Development
11.10 Poly-Dtech
11.10.1 Poly-Dtech Company Details
11.10.2 Poly-Dtech Business Overview
11.10.3 Poly-Dtech Lateral Flow Assay Services Introduction
11.10.4 Poly-Dtech Revenue in Lateral Flow Assay Services Business (2020-2025)
11.10.5 Poly-Dtech Recent Development
11.11 Lumos Diagnostics
11.11.1 Lumos Diagnostics Company Details
11.11.2 Lumos Diagnostics Business Overview
11.11.3 Lumos Diagnostics Lateral Flow Assay Services Introduction
11.11.4 Lumos Diagnostics Revenue in Lateral Flow Assay Services Business (2020-2025)
11.11.5 Lumos Diagnostics Recent Development
11.12 RAPIvD ltd
11.12.1 RAPIvD ltd Company Details
11.12.2 RAPIvD ltd Business Overview
11.12.3 RAPIvD ltd Lateral Flow Assay Services Introduction
11.12.4 RAPIvD ltd Revenue in Lateral Flow Assay Services Business (2020-2025)
11.12.5 RAPIvD ltd Recent Development
11.13 JOYSBIO
11.13.1 JOYSBIO Company Details
11.13.2 JOYSBIO Business Overview
11.13.3 JOYSBIO Lateral Flow Assay Services Introduction
11.13.4 JOYSBIO Revenue in Lateral Flow Assay Services Business (2020-2025)
11.13.5 JOYSBIO Recent Development
11.14 Leinco
11.14.1 Leinco Company Details
11.14.2 Leinco Business Overview
11.14.3 Leinco Lateral Flow Assay Services Introduction
11.14.4 Leinco Revenue in Lateral Flow Assay Services Business (2020-2025)
11.14.5 Leinco Recent Development
11.15 Leadgene Biomedical
11.15.1 Leadgene Biomedical Company Details
11.15.2 Leadgene Biomedical Business Overview
11.15.3 Leadgene Biomedical Lateral Flow Assay Services Introduction
11.15.4 Leadgene Biomedical Revenue in Lateral Flow Assay Services Business (2020-2025)
11.15.5 Leadgene Biomedical Recent Development
11.16 Biotem
11.16.1 Biotem Company Details
11.16.2 Biotem Business Overview
11.16.3 Biotem Lateral Flow Assay Services Introduction
11.16.4 Biotem Revenue in Lateral Flow Assay Services Business (2020-2025)
11.16.5 Biotem Recent Development
11.17 Biocompare
11.17.1 Biocompare Company Details
11.17.2 Biocompare Business Overview
11.17.3 Biocompare Lateral Flow Assay Services Introduction
11.17.4 Biocompare Revenue in Lateral Flow Assay Services Business (2020-2025)
11.17.5 Biocompare Recent Development
11.18 nanoComposix
11.18.1 nanoComposix Company Details
11.18.2 nanoComposix Business Overview
11.18.3 nanoComposix Lateral Flow Assay Services Introduction
11.18.4 nanoComposix Revenue in Lateral Flow Assay Services Business (2020-2025)
11.18.5 nanoComposix Recent Development
11.19 Creative Diagnostics
11.19.1 Creative Diagnostics Company Details
11.19.2 Creative Diagnostics Business Overview
11.19.3 Creative Diagnostics Lateral Flow Assay Services Introduction
11.19.4 Creative Diagnostics Revenue in Lateral Flow Assay Services Business (2020-2025)
11.19.5 Creative Diagnostics Recent Development
11.20 Lateral Dx
11.20.1 Lateral Dx Company Details
11.20.2 Lateral Dx Business Overview
11.20.3 Lateral Dx Lateral Flow Assay Services Introduction
11.20.4 Lateral Dx Revenue in Lateral Flow Assay Services Business (2020-2025)
11.20.5 Lateral Dx Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 麻豆原创 Size Estimation
13.1.1.3 麻豆原创 Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
Sigma-Aldrich
BBI Solutions
RayBiotech
DCN Dx
Fortis Life Sciences
Cytodiagnostics
Abingdon Health
Cytiva
Attogene
Poly-Dtech
Lumos Diagnostics
RAPIvD ltd
JOYSBIO
Leinco
Leadgene Biomedical
Biotem
Biocompare
nanoComposix
Creative Diagnostics
Lateral Dx
听
听
*If Applicable.
